TRCT
DRIO icon

Tower Research Capital (TRC)’s DarioHealth DRIO Stock Holding History

Tower Research Capital (TRC)’s Portfolio DRIO Stock Details DRIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-448
Closed -$3.59K – 5307
2026
Q1 		$3.59K Buy
448
+39
+10% +$407 ﹤0.01% 4294
2025
Q4 		$4.65K Sell
409
-502
-55% -$6.62K ﹤0.01% 4194
2025
Q3 		$15.8K Sell
911
-38
-4% -$419 ﹤0.01% 3520
2025
Q2 		$12.7K Buy
949
+756
+392% +$10.5K ﹤0.01% 3881
2025
Q1 		$2.36K Sell
193
-186
-49% -$2.63K ﹤0.01% 4559
2024
Q4 		$5.95K Buy
379
+96
+34% +$1.66K ﹤0.01% 4221
2024
Q3 		$6.35K Buy
283
+47
+20% +$953 ﹤0.01% 4158
2024
Q2 		$5.63K Buy
236
+16
+7% +$453 ﹤0.01% 4667
2024
Q1 		$6.74K Sell
220
-7
-3% -$265 ﹤0.01% 4327
2023
Q4 		$7.79K Buy
227
+214
+1,646% +$7.62K ﹤0.01% 4577
2023
Q3 		$823 Buy
13
+8
+160% +$539 ﹤0.01% 5470
2023
Q2 		$401 Sell
5
-13
-72% -$987 ﹤0.01% 5658
2023
Q1 		$1K Buy
+18
New +$1.77K ﹤0.01% 5519
2022
Q2 		– Sell
-109
Closed -$12K – 6152
2022
Q1 		$12K Buy
109
+8
+8% +$1.32K ﹤0.01% 4052
2021
Q4 		$26K Buy
101
+73
+261% +$22.2K ﹤0.01% 3379
2021
Q3 		$8K Sell
28
-108
-79% -$31.2K ﹤0.01% 4529
2021
Q2 		$58K Buy
136
+52
+62% +$19.8K ﹤0.01% 2903
2021
Q1 		$32K Buy
84
+82
+4,100% +$36.9K ﹤0.01% 3513
2020
Q4 		$1K Sell
2
-21
-91% -$5.41K ﹤0.01% 4988
2020
Q3 		$8K Sell
23
-46
-67% -$12.4K ﹤0.01% 4171
2020
Q2 		$9K Buy
+69
New +$9.17K ﹤0.01% 4049
2016
Q4 		– Sell
-2
Closed -$3K – 3918
2016
Q3 		$3K Sell
2
-1
-33% -$1.57K ﹤0.01% 2824
2016
Q2 		$5K Sell
3
-1
-25% -$2.04K ﹤0.01% 3361
2016
Q1 		$7K Buy
+4
New +$6.19K ﹤0.01% 2347

Other funds holding DRIO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $215B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Tower Research Capital (TRC)'s DRIO Position: Q2 2026 in Review

Tower Research Capital (TRC) sold out of DarioHealth (DRIO) in Q2 2026, closing a stake of 448 shares — an estimated $3.59K sold.

Tower Research Capital (TRC) first reported a position in DRIO in Q1 2016 and held it in 24 quarters. The position peaked at $58K in Q2 2021. 21 funds tracked by Wall St. Rank hold DRIO as of Q2 2026.

  • Tower Research Capital (TRC) reported no remaining DarioHealth position as of Q2 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 448 DarioHealth shares in Q2 2026, an estimated $3.59K.
  • Tower Research Capital (TRC) first reported a position in DarioHealth in Q1 2016 and held it in 24 quarters.
  • Tower Research Capital (TRC)'s DarioHealth position peaked at $58K in Q2 2021.
  • 21 funds tracked by Wall St. Rank held DarioHealth as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.